3D Kinematics Quantifies Gait Response to Levodopa earlier and to a more Comprehensive Extent than the MDS-Unified Parkinson's Disease Rating Scale in Patients with Motor Complications.
Raquel BarbosaMarcelo D MendonçaPaulo André Dias BastosPatrícia Pita LoboAnabela ValadasLeonor Correia GuedesJoaquim J FerreiraMário Miguel RosaRicardo MatiasMiguel CoelhoPublished in: Movement disorders clinical practice (2024)
IMUs are capable of detecting motor alterations earlier and in a more comprehensive manner than the MDS-UPDRS III. The upper limbs respond more rapidly to levodopa, possibly reflecting distinct thresholds to levodopa across striatal regions.